review Open AccessTop 1% cited
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
Alimentary Pharmacology & Therapeutics · 2009 · Vol. 31(2) · pp. 169–188
Irvin Modlin✉(Yale University)Marianne Pavel(Charité - Universitätsmedizin Berlin)Mark Kidd(Yale University)Björn Gustafsson(St Olav's University Hospital)
Abstract
As more precise understanding of NET cell biology evolves and molecular biological tools advance, more accurate identification of individual tumours sstr profile will probably facilitate a more precise delineation of SST analogue treatment.
Neuroendocrine Tumor Research AdvancesNeuroblastoma Research and TreatmentsLung Cancer Research StudiesPasireotideLanreotideSomatostatinSomatostatin receptorNeuroendocrine tumorsMedicineOctreotideCarcinoid syndromeSomatostatin AnalogueInternal medicine
MeSH terms
Antineoplastic AgentsCarcinoid TumorGastrointestinal NeoplasmsHormonesHumansPancreatic NeoplasmsSomatostatinTreatment OutcomeReceptors, Somatostatin
Funding
- Ipsen
Citations
404
FWCI
14.64
field-weighted impact
References
151
Percentile
99%
vs. same field & year
Citations per year
Cited by
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2020 · 1,102 citations
References
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Life Sciences · 1982 · 1,328 citations
Pasireotide (SOM230): Development, mechanism of action and potential applications
Molecular and Cellular Endocrinology · 2007 · 286 citations
Gastroenteropancreatic neuroendocrine tumours
The Lancet Oncology · 2008 · 1,743 citations
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Journal of Clinical Oncology · 2009 · 2,474 citations
SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
European Journal of Endocrinology · 2002 · 683 citations
Related articles
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
Alimentary Pharmacology & Therapeutics · 2009 · 404 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.